Showing results (51-60 of 156) with videos related to
Sort By:
Pageof 16
Bone and Mineral|July 1, 1993
Urinary collagen crosslink excretion: a better index of bone resorption than hydroxyproline in Paget's disease of bone?N A Hamdy, S E Papapoulos, A Colwell, et al.Bone|November 21, 1998
Binding and antiresorptive properties of heterocycle-containing bisphosphonate analogs: structure-activity relationshipsE R van Beek, C W Löwik, F H Ebetino, et al.The Journal of Clinical Investigation|April 1, 1994
Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorptionC W Löwik, P H Nibbering, M van de Ruit, et al.Acta Endocrinologica|April 1, 1980
The long-term effect of lowering dialysate magnesium on circulating parathyroid hormone in patients on regular haemodialysis therapyV Parsons, S E Papapoulos, M J Weston, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 1, 1989
Application of an in vitro model and a clinical protocol in the assessment of the potency of a new bisphosphonateS E Papapoulos, K Hoekman, C W Löwik, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 1999
Interleukin-17: A new bone acting cytokine in vitroR L Van bezooijen, H C Farih-Sips, S E Papapoulos, et al.European Journal of Nuclear Medicine|January 1, 1989
The reproducibility of single photon absorptiometry in a clinical settingR Valkema, J A Blokland, S E Papapoulos, et al.The Quarterly Journal of Medicine|October 1, 1978
Studies of hypoparathyroidism and pseudohypoparathyroidismI G Lewin, S E Papapoulos, S Tomlinson, et al.Clinical Science (London, England : 1979)|June 1, 1990
Atrial natriuretic peptide and chronic renal effects of changes in dietary protein and sodium intake in manC J Doorenbos, J A Iestra, S E Papapoulos, et al.European Journal of Endocrinology|September 7, 2010
Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controlsA H van Lierop, J E Witteveen, N A T Hamdy, et al.Pageof 16